Trends of all-cause, melanoma-specific, and cardiovascular mortality in melanoma patients from 2005 to 2020
Cancer Epidemiology · 2025
DOI: 10.1016/j.canep.2025.102848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Epidemiology, 2025. Verfasst von Astha Prasai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Rochester Regional Health, Rochester, NY, USA. Hauptthemen laut MEDLINE: Melanoma, Cardiovascular Diseases, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Recent advances in melanoma treatment, including immunotherapy and targeted therapy, have significantly improved survival among melanoma patients after 2010. However, these changes may have influenced mortality trends, including those related to cardiovascular (CV) events. OBJECTIVE: In this study, we assess mortality trends including CV mortality in melanoma patients. METHODS: Using data from the Surveillance, Epidemiology, and End Results (SEER) 17 registry, we examined melanoma incidence and CV, melanoma-specific, and all-cause mortalities from 2005 to 2020. We utilized Joinpoint software to estimate the annual percentage change (APC). RESULTS: Our study included 299,993 melanoma patients (173,889 males; 126,104 females). The incidence of melanoma increased by 0.6 % annually (95 % CI: 0.3-1.5, p < 0.05) from 2005 to 2019, followed by a 6.3 % decrease (95 % CI: -9.9 to -0.7, p < 0.05) in 2020. All-cause mortality increased annually by 8.3 % (95 % CI: 6.7-11.3, p < 0.05) from 2005 to 2010, then by 3.3 % (95 % CI: 2.8-3.7, p < 0.05) after 2010. Melanoma-specific mortality increased by 2.0 % annually (95 % CI: 0.8-3.5, p < 0.05) from 2005 until 2013, after which it declined by 5.1 % (95 % CI: -7.3 to -3.8, p < 0.05). CV mortality increased by 7.1 % annually (95 % CI: 4.6-9.4, p < 0.05) from 2005 to 2020. Trends were similar across sexes, with a non-significant higher APC in CV mortality noted among females from 2017 to 2020. CONCLUSIONS: Our study shows despite the significant decrease in all-cause and melanoma-specific mortalities after 2010, likely reflecting the benefits of modern therapies, CV mortality continued to rise. These findings underscore the need for long-term surveillance and CV risk management in melanoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Rochester Regional Health, Rochester, NY, USA.
- Columbia University Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL, USA.
- Department of Internal Medicine, Hartford Hospital, Hartford, CT, USA.
- Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Internal Medicine, Rochester Regional Health, Rochester, NY, USA; Department of Cardiology, Sands, Constellation Heart Institute, Rochester Regional Health, Rochester, NY, USA.
- Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Zitieren
APA
Prasai, A., Baral, N., Elajami, M. K., Vallabhaneni, E., Mitchell, J. D., Iqbal, U., Bahmad, H. F., Welty, F. K., & Elajami, T. K. (2025). Trends of all-cause, melanoma-specific, and cardiovascular mortality in melanoma patients from 2005 to 2020. Cancer Epidemiology. https://doi.org/10.1016/j.canep.2025.102848
Vancouver
Prasai A, Baral N, Elajami MK, Vallabhaneni E, Mitchell JD, Iqbal U, et al. Trends of all-cause, melanoma-specific, and cardiovascular mortality in melanoma patients from 2005 to 2020. Cancer Epidemiology. 2025. doi:10.1016/j.canep.2025.102848
BibTeX
@article{Prasai2025,
author = {Prasai, Astha and Baral, Nischit and Elajami, Mohamad K and Vallabhaneni, Esha and Mitchell, Joshua D and Iqbal, Uzma and Bahmad, Hisham F and Welty, Francine K and Elajami, Tarec K},
title = {Trends of all-cause, melanoma-specific, and cardiovascular mortality in melanoma patients from 2005 to 2020},
journal = {Cancer Epidemiology},
year = {2025},
doi = {10.1016/j.canep.2025.102848}
}
EUVIMED